Valuation : AtriCure, Inc.

Market Cap 2.68B 2.31B 2.17B 1.98B 3.7B 253B 3.73B 25.74B 9.99B 129B 10.05B 9.83B 424B P/E 2026 *
498x
P/E 2027 * 126x
Enterprise Value 2.52B 2.18B 2.05B 1.87B 3.49B 238B 3.52B 24.27B 9.42B 122B 9.47B 9.27B 400B EV / Sales 2026 *
4.16x
EV / Sales 2027 * 3.6x
Free-Float
96.21%
Yield 2026 *
-
Yield 2027 * -
1 day+7.50%
1 week+9.18%
Current month+8.77%
1 month+39.27%
3 months+103.36%
6 months+70.03%
Current year+32.94%
1 week 46.61
Extreme 46.6101
52.69
1 month 37.98
Extreme 37.98
52.69
Current year 25.36
Extreme 25.36
52.69
1 year 25.36
Extreme 25.36
52.69
3 years 18.94
Extreme 18.94
52.69
5 years 18.94
Extreme 18.94
89.18
10 years 14.78
Extreme 14.78
89.18
Manager TitleAgeSince
Chief Executive Officer 55 2012-11-01
Director of Finance/CFO 48 2014-06-30
Chief Tech/Sci/R&D Officer 59 2017-07-17
Director TitleAgeSince
Director/Board Member 55 2012-11-01
Director/Board Member 64 2013-03-10
Director/Board Member 75 2016-11-09
Date Insider Type Main position Quantity % Market Cap. Importance
8/24/26 Sell

General Counsel

-9,370 0.0184%
8/5/26 Sell

Director

-3,500 0.0069%
8/5/26 Sell

Director

-3,564 0.0070%
Change 5-day change 1-year change 3-year change Capi.($)
+7.50%+9.18%+44.92%+15.05% 2.49B
+1.41%-3.18%-15.97%+7.41% 188B
+0.15%+0.17%-1.23%+12.24% 118B
+1.63%+2.61%+14.08%+92.25% 63.16B
+0.08%-0.06%+25.22%+48.72% 52.01B
+0.21%-1.41%-0.33%-32.66% 50.97B
-0.50%+0.82%+20.71%-11.98% 34.02B
+3.39%+4.97% - - 30.8B
+1.18%-2.08%+40.57%-15.96% 23.83B
-0.08%-3.65%-6.29%+13.56% 23.45B
Average +1.45%+0.47%+13.52%+14.29% 58.7B
Weighted average by Cap. +0.82%-1.67%+1.20%+16.36%

Financials

2026 *2027 *
Net sales 606M 523M 493M 449M 839M 57.27B 845M 5.83B 2.26B 29.28B 2.28B 2.23B 96.18B 680M 586M 552M 503M 941M 64.2B 948M 6.54B 2.54B 32.82B 2.55B 2.5B 108B
Net income 7.11M 6.14M 5.78M 5.27M 9.84M 672M 9.92M 68.43M 26.56M 344M 26.71M 26.12M 1.13B 20.78M 17.92M 16.88M 15.38M 28.76M 1.96B 28.97M 200M 77.58M 1B 78.02M 76.31M 3.3B
Net Debt -152M -131M -124M -113M -211M -14.37B -212M -1.46B -568M -7.35B -571M -559M -24.13B -226M -195M -184M -168M -313M -21.38B -316M -2.18B -845M -10.93B -850M -831M -35.9B
Logo AtriCure, Inc.
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
Employees
1,350
Date Price Change Volume
26-09-02 $52.59 +7.50% 1,262,638
26-09-01 $48.92 +1.18% 718,136
26-08-31 $48.35 -0.39% 529,117
26-08-28 $48.54 -1.48% 390,633
26-08-27 $49.27 +2.28% 766,479
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
52.59USD
Average target price
51.67USD
Spread / Average Target
-1.76%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ATRC Stock